CN470 is a BET/CBP/p300 multi-bromodomain inhibitor and has an anti-tumor activity against MLL-rearranged acute lymphoblastic leukemia.
Imayoshi N, Yoshioka M, Tanaka K, Yang SM, Akahane K, Toda Y, Hosogi S, Inukai T, Okada S, Maloney DJ, Nakahata T, Takita J, Kato I, Ashihara E.
Imayoshi N, et al. Among authors: ashihara e.
Biochem Biophys Res Commun. 2022 Jan 29;590:49-54. doi: 10.1016/j.bbrc.2021.12.078. Epub 2021 Dec 24.
Biochem Biophys Res Commun. 2022.
PMID: 34971957
Free PMC article.